Metformin hydrochloride
Xuvelex XR contains the active substance metformin hydrochloride and belongs to a group of medicines called biguanides, used to treat patients with type 2 diabetes (also called non-insulin-dependent diabetes).
Xuvelex XR is used to treat type 2 diabetes when diet and exercise alone have not been able to control blood sugar levels. It is used especially in patients who are overweight. Insulin is a hormone that allows the body to take up glucose from the blood and use it for energy or store it for future use.
In patients with type 2 diabetes, the pancreas does not produce enough insulin or the body is unable to use the insulin produced. This leads to high blood sugar levels, which can cause a number of serious, long-term problems, so it is important to continue taking the medicine, even if no symptoms are present.
Xuvelex XR increases the body's sensitivity to insulin and helps restore normal glucose use.
If the patient is overweight, taking Xuvelex XR for a longer period reduces the risk of complications associated with diabetes. Taking Xuvelex XR is associated with maintaining weight or moderate weight loss.
Xuvelex XR is a prolonged-release tablet that is specially designed to release the medicine slowly in the body and therefore differs from many other types of metformin tablets.
If any of the above situations apply to you, consult your doctor before taking this medicine.
It is essential to consult your doctor if:
Before taking Xuvelex XR, talk to your doctor.
Xuvelex XR may cause a very rare but very serious side effect called lactic acidosis, especially if you have kidney problems. The risk of lactic acidosis also increases in case of uncontrolled diabetes, severe infection, prolonged fasting, or excessive alcohol consumption, dehydration (see more information below), liver problems, and any conditions in which a part of the body is not adequately supplied with oxygen (e.g., acute severe heart disease).
If any of the above conditions apply to you, consult your doctor for more detailed instructions.
(significant fluid loss), such as severe vomiting, diarrhea, fever, exposure to high temperatures, or if you drink less fluid than usual. Consult your doctor for more detailed instructions.
because this condition can lead to coma.
Symptoms of lactic acidosis include:
Lactic acidosis is a life-threatening condition that requires immediate hospital treatment.
If you are going to have a major surgical procedure, you must stop taking Xuvelex XR during and for some time after the procedure. Your doctor will decide when you should stop and restart Xuvelex XR treatment.
Xuvelex XR does not cause hypoglycemia (low blood sugar).
However, if Xuvelex XR is taken with other anti-diabetic medicines that can cause hypoglycemia (such as sulfonylurea derivatives, insulin, meglitinides), there is a risk of hypoglycemia. If symptoms of hypoglycemia occur, such as weakness, dizziness, increased sweating, rapid heartbeat, vision disturbances, or difficulty concentrating, eating or drinking something containing sugar usually helps.
During treatment with Xuvelex XR, your doctor will check your kidney function at least once a year or more often if you are elderly and/or have impaired kidney function.
Tablet residues may be visible in the stool. Do not worry, as this is normal when taking this type of tablet.
Follow all dietary recommendations given by your doctor and make sure you eat the recommended amount of carbohydrates distributed throughout the day.
Do not stop taking this medicine without consulting your doctor.
Due to the lack of data, Xuvelex XR should not be used in children and adolescents.
If you are going to have a contrast agent containing iodine injected into your bloodstream, for example, for an X-ray examination or computed tomography, you must stop taking Xuvelex XR before or at the latest at the time of injection. Your doctor will decide when you should stop and restart Xuvelex XR treatment.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take. You may need more frequent blood sugar checks and kidney function tests or dose adjustments of Xuvelex XR by your doctor. It is especially important to inform about the following medicines:
Avoid excessive alcohol consumption while taking Xuvelex XR, as this may increase the risk of lactic acidosis (see "Warnings and precautions").
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor before taking this medicine.
If you are pregnant, think you may be pregnant, or plan to have a child, consult your doctor in case any changes in treatment or blood sugar control are necessary.
This medicine is not recommended if you are breastfeeding or plan to breastfeed.
Xuvelex XR taken alone does not cause hypoglycemia (symptoms of low blood sugar or hypoglycemia, such as fainting, confusion, and increased sweating), and therefore should not affect your ability to drive or use machines.
However, remember that Xuvelex XR taken with other anti-diabetic medicines (such as sulfonylurea derivatives, insulin, meglitinides) may cause hypoglycemia, so be careful when driving or using machines in such cases.
This medicine contains less than 1 mmol (23 mg) of sodium per prolonged-release tablet, which means that the medicine is essentially "sodium-free".
Your doctor may prescribe Xuvelex XR alone or in combination with other oral anti-diabetic medicines or insulin.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Xuvelex XR does not replace the benefits of a healthy lifestyle. You should continue to follow all dietary recommendations given by your doctor and exercise regularly.
Recommended dose for adults
Treatment usually starts with 500 mg of Xuvelex XR taken once a day. After about 2 weeks of taking Xuvelex XR, your doctor may adjust the dose based on blood sugar measurements. The maximum daily dose of Xuvelex XR is 2000 mg.
If you have reduced kidney function, your doctor may prescribe a lower dose.
If you are also taking insulin, your doctor will tell you how to start taking Xuvelex XR.
Treatment monitoring
How to take Xuvelex XR
Usually, the tablets are taken once a day during the evening meal. This will help avoid gastrointestinal side effects.
In some cases, your doctor may recommend taking the tablets twice a day. The tablets should always be taken with food.
The tablets should be swallowed whole with a glass of water; do not crush or chew them.
If you take a higher dose of Xuvelex XR than recommended, you may experience lactic acidosis. The symptoms of lactic acidosis are non-specific, such as vomiting, abdominal pain (stomach pain) with muscle cramps, general feeling of being unwell with severe fatigue, and breathing difficulties. Other symptoms include decreased body temperature and slowed heart rate. If you experience any of these symptoms, seek medical help immediately, as lactic acidosis can lead to coma. You should stop taking Xuvelex XR and contact your doctor or the nearest hospital immediately.
Take the missed tablet as soon as you remember or take the next dose at the usual time with food. Do not take a double dose to make up for the missed dose.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Xuvelex XR can cause side effects, although not everybody gets them.
The following side effects may occur:
Xuvelex XRmay very rarely (may occur in up to 1 in 10,000 patients) cause a very serious side effect called lactic acidosis (see "Warnings and precautions"). If this occurs, stop taking Xuvelex XR and contact your doctor or the nearest hospital immediately, as lactic acidosis can lead to coma.
Xuvelex XR may cause changes in liver function test results and liver inflammation, which can cause jaundice (may occur in up to 1 in 10,000 patients). If you experience yellowing of the eyes and/or skin stop taking Xuvelex XR and contact your doctor immediately.
Other possible side effects are listed below by frequency of occurrence:
Common (may affect up to 1 in 10 people):
Very rare (may affect up to 1 in 10,000 people):
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton after "EXP".
The expiry date refers to the last day of the month.
Store in a temperature below 25°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is metformin hydrochloride.
Xuvelex XR, 500 mg prolonged-release tablets:
each prolonged-release tablet contains 500 mg of metformin hydrochloride, which corresponds to 389.938 mg of metformin.
Xuvelex XR, 750 mg prolonged-release tablets:
each prolonged-release tablet contains 750 mg of metformin hydrochloride, which corresponds to 584.907 mg of metformin.
Xuvelex XR, 1000 mg prolonged-release tablets:
each prolonged-release tablet contains 1000 mg of metformin hydrochloride, which corresponds to 779.876 mg of metformin.
The other ingredients are: povidone K-90F, colloidal silica, sodium carmellose 2500-3500 mPa·s, hypromellose 10,000 cps, microcrystalline cellulose, magnesium stearate.
Description
Xuvelex XR, 500 mg prolonged-release tablets: white or almost white, rounded, biconvex tablets with "500" embossed on one side and smooth on the other side.
The tablets are approximately 12.15 mm in diameter.
Xuvelex XR, 750 mg prolonged-release tablets: white or almost white, biconvex tablets in the shape of a capsule with "750" embossed on one side and smooth on the other side. The tablets are approximately 20.0 mm long and 9.6 mm wide.
Xuvelex XR, 1000 mg prolonged-release tablets: white or almost white, biconvex tablets in the shape of a capsule with "1000" embossed on one side and smooth on the other side. The tablets are approximately 22.6 mm long and 10.6 mm wide.
Xuvelex XR, 500 mg prolonged-release tablets: the tablets are available in PVC/PVDC/Aluminum blisters of 20, 30, 60, and 90 tablets.
Xuvelex XR, 750 mg prolonged-release tablets: the tablets are available in PVC/PVDC/Aluminum blisters of 20, 30, 60, and 90 tablets.
Xuvelex XR, 1000 mg prolonged-release tablets: the tablets are available in PVC/PVDC/Aluminum blisters of 10, 30, 60, and 90 tablets.
Not all pack sizes may be marketed.
Egis Pharmaceuticals PLC
Keresztúri út 30-38
1106 Budapest
Hungary
PharOS MT Ltd.
HF62X, Hal Far Industrial Estate
Birzebbugia, BBG3000, Malta
Hungary
Xuvelex XR 500mg, 750mg & 1000mg, Retard tabletta
Czech Republic
Xuvelex
Poland
Xuvelex XR
Romania
Xuvelex XR 500mg, 750mg & 1000mg, Comprimat cu eliberare prelungită
To obtain more detailed information on this medicine, contact the local representative of the marketing authorization holder:
EGIS Polska sp. z o.o.
ul. Komitetu Obrony Robotników 45D
02-146 Warsaw
Phone: +48 22 417 92 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.